Võrdle meetodeid

	Pragmaatiline diagnostilise täpsuse uuring	Sõeluuringute hindamine – sõeluuringute ja -programmide hindamine
Valdkond	Epidemioloogia	Epidemioloogia
Perekond	Process / pipeline	Process / pipeline
Tekkeaasta	2000s–2010s (formalized alongside STARD reporting guidelines)	1968 (Wilson-Jungner principles); statistical framework developed 1970s–2000s
Looja	Evolved from STARD initiative (Bossuyt et al.) and pragmatic trial framework (Schwartz & Lellouch, 1967)	Wilson & Jungner (WHO criteria, 1968); foundational work by Pepe, Altman, and others in statistical test evaluation
Tüüp	Observational diagnostic study design	Observational diagnostic / epidemiological evaluation design
Algallikas	Bossuyt, P. M., et al. (2015). STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. BMJ, 351, h5527.	Wilson, J. M. G., & Jungner, G. (1968). Principles and Practice of Screening for Disease. World Health Organization. Public Health Papers No. 34.
Rööpnimetused	real-world diagnostic accuracy study, pragmatic DAS, routine-care diagnostic study, pragmatic test evaluation	screening study, screening performance evaluation, screening accuracy assessment, STE
Seotud	6	6
Kokkuvõte	A pragmatic diagnostic accuracy study evaluates how well a diagnostic test performs under real-world clinical conditions — not in idealized, tightly controlled settings. Conducted within routine care workflows, it measures sensitivity, specificity, predictive values, and likelihood ratios for an index test against a reference standard, yielding accuracy estimates directly applicable to clinical practice rather than laboratory benchmarks.	Screening test evaluation is a systematic epidemiological approach for assessing whether a test or program can accurately and cost-effectively identify individuals with a condition before symptoms appear. It quantifies diagnostic performance metrics — sensitivity, specificity, predictive values, and the ROC curve — and evaluates whether a screening program meets established public health criteria for adoption and harm-benefit balance.